TSE:3281 stock news
This page provides real-time market news, earnings updates, and company announcements related to GLP J-REIT (TSE:3281).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-05-07 04:07 JST
新浪财经2026-04-02 13:11:49
Weight Watchers Announces Leadership Transition and Board Updates
Finviz2026-04-03 18:12:50
CORRECTION -- AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results
Finviz2026-04-06 10:33:42
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
Finviz2026-04-07 11:33:11
iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia
Finviz2026-04-08 11:03:43
Foundayo (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
Finviz2026-04-09 10:48:06
Weight Watchers Announces Board Committee Appointments
Finviz2026-04-09 11:33:50
LifeVantage to Participate in Water Tower Research Insights Conference on Wednesday, April 15, 2026
Finviz2026-04-09 20:09:47
Viking Therapeutics to Participate at Upcoming Investor Conferences
Finviz2026-04-10 11:36:45
Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
Finviz2026-04-13 12:03:58
Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide
Finviz2026-04-13 21:27:11
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
Finviz2026-04-14 12:06:47
MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026
Finviz2026-04-14 12:33:59
Hims has surged more than 50% this week, as investors focus on the impact of Trump’s Secretary of Health peptide-related policies on the company’s GLP-1 weight-loss drug business transformation.
华尔街见闻2026-04-17 13:53:01
Overnight News Highlights for April 22
老虎证券2026-04-21 22:41:06
Amazon launches GLP-1 weight loss drug program through its subsidiary One Medical
格隆汇2026-04-22 01:00:03
Novo Nordisk (NVO.US) oral GLP-1 drug achieves primary endpoint in adolescent trial, plans to apply for new indication in the second half of 2026
老虎证券2026-04-23 11:48:34
Hims & Hers Health launches multiple GLP-1 drugs approved by the US FDA
格隆汇2026-04-23 14:33:34
Earnings Preview | Strong Growth Almost Certain, Eli Lilly's Real Test in Q1 Lies in Foundayo Debut and "Post-GLP-1 Era" Technological Moat
老虎证券2026-04-28 07:03:01
Eli Lilly Q1 2026 Earnings Preview: GLP-1 Sustained High Growth, Oral Drug Foundayo as Valuation Catalyst
Bitget2026-04-29 05:57:38
Eli Lilly (LLY) closed up 9.80% with a trading volume of $7.604 billion; the FDA proposes to remove semaglutide and tirzepatide from the bulk compounding list, benefiting original drugs by Eli Lilly and Novo Nordisk
今日美股网2026-05-01 02:11:11
Eli Lilly (LLY) Q1 2026 Earnings Highlights: GLP-1 Momentum Fuels Strong Beat, Guidance Raised
Bitget2026-05-01 04:54:07
The $30 Stock Wall Street Values at $93?
TradingView2026-05-04 14:45:14
$NVO Despite expectations, Wegovy may retain its lead longer
TradingView2026-05-04 20:45:17
iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia
Finviz2026-04-08 11:03:43
Foundayo (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
Finviz2026-04-09 10:48:06
Weight Watchers Announces Board Committee Appointments
Finviz2026-04-09 11:33:50
LifeVantage to Participate in Water Tower Research Insights Conference on Wednesday, April 15, 2026
Finviz2026-04-09 20:09:47
Viking Therapeutics to Participate at Upcoming Investor Conferences
Finviz2026-04-10 11:36:45
Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
Finviz2026-04-13 12:03:58
Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide
Finviz2026-04-13 21:27:11
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
Finviz2026-04-14 12:06:47
MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026
Finviz2026-04-14 12:33:59
Hims has surged more than 50% this week, as investors focus on the impact of Trump’s Secretary of Health peptide-related policies on the company’s GLP-1 weight-loss drug business transformation.
华尔街见闻2026-04-17 13:53:01
Overnight News Highlights for April 22
老虎证券2026-04-21 22:41:06
Amazon launches GLP-1 weight loss drug program through its subsidiary One Medical
格隆汇2026-04-22 01:00:03
Novo Nordisk (NVO.US) oral GLP-1 drug achieves primary endpoint in adolescent trial, plans to apply for new indication in the second half of 2026
老虎证券2026-04-23 11:48:34
Hims & Hers Health launches multiple GLP-1 drugs approved by the US FDA
格隆汇2026-04-23 14:33:34
Earnings Preview | Strong Growth Almost Certain, Eli Lilly's Real Test in Q1 Lies in Foundayo Debut and "Post-GLP-1 Era" Technological Moat
老虎证券2026-04-28 07:03:01
Eli Lilly Q1 2026 Earnings Preview: GLP-1 Sustained High Growth, Oral Drug Foundayo as Valuation Catalyst
Bitget2026-04-29 05:57:38
Eli Lilly (LLY) closed up 9.80% with a trading volume of $7.604 billion; the FDA proposes to remove semaglutide and tirzepatide from the bulk compounding list, benefiting original drugs by Eli Lilly and Novo Nordisk
今日美股网2026-05-01 02:11:11
Eli Lilly (LLY) Q1 2026 Earnings Highlights: GLP-1 Momentum Fuels Strong Beat, Guidance Raised
Bitget2026-05-01 04:54:07
The $30 Stock Wall Street Values at $93?
TradingView2026-05-04 14:45:14
$NVO Despite expectations, Wegovy may retain its lead longer
TradingView2026-05-04 20:45:17
TSE:3281 stock price change
On the last trading day, TSE:3281 stock closed at 135200.00 JPY, with a price change of -0.22% for the day.
Trade stock perpsTSE:3281 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more